Is sarcoidosis related to metabolic syndrome and insulin resistance?

References

• Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153–2165.
   PubMed Web of Science ®Google Scholar
• Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999;14:735–737.
   PubMedGoogle Scholar
• Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1224–1234.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes federation task force on epidemiology and prevention. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Jensen MD, Ryan DH, Apovian CM. 2013AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129:102–138.
   PubMed Web of Science ®Google Scholar
• Cozier YC, Govender P, Berman JS. Obesity and sarcoidosis: consequence or contributor? Curr Opin Pulm Med. 2018;24:487–494.
   PubMed Web of Science ®Google Scholar
• Crowson CS, Matteson EL, Davis JM, 3rd, et al. Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013;65:71–77.
   PubMed Web of Science ®Google Scholar
• Love TJ, Zhu Y, Zhang Y, et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis. 2012;71:1273–1277.
   PubMed Web of Science ®Google Scholar
• Harpsoe MC, Basit S, Andersson M, et al. Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int J Epidemiol. 2014;43:843–855.
   PubMed Web of Science ®Google Scholar
• Kassi E, Pervanidou P, Kaltsas G, et al. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48.
   PubMed Web of Science ®Google Scholar
• Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009;32:2297–2299.
   PubMed Web of Science ®Google Scholar
• Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA. 2011;305:391.
   PubMed Web of Science ®Google Scholar
• Cozier YC, Coogan PF, Govender P, et al. Obesity and weight gain in relation to incidence of sarcoidosis in US black women: data from the Black Women's Health Study . Chest. 2015;147:1086–1093.
   PubMed Web of Science ®Google Scholar
• Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2013;385:1155–1167.
   Google Scholar
• Gerke AK, Hunninghake G. The immunology of sarcoidosis. Clin Chest Med. 2008;29:379–390.
   PubMed Web of Science ®Google Scholar
• Esser N, Legrand-Poels S, Piette J, et al. Inflammation as a link between obesity, metabolic syndrome and T2D. Diabetes Res Clin Pract. 2014;105:141–150.
   PubMed Web of Science ®Google Scholar
• Pohl J, Woodside B, Luheshi GN. Changes in hypothalamically mediated acute-phase inflammatory responses to lipopolysaccharide in diet-induced obese rat. Endocrinology. 2009;150:4901–4910.
   PubMed Web of Science ®Google Scholar
• Clarke MA, Stefanidis A, Spencer SJ. Postnatal overfeeding leads to obesity and exacerbated febrile responses to lipopolysaccharide throughout life. J Neuroendocrinol. 2012;24:511–524.
   PubMed Web of Science ®Google Scholar
• Das UN. Is obesity an inflammatory condition? Nutrition. 2001;17:953.
   PubMed Web of Science ®Google Scholar
• Dagur PK1, Biancotto A, Wei L, et al. MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases. J Autoimmun. 2011;37:319–327.
   PubMed Web of Science ®Google Scholar
• Matarese G, Leiter EH, La C. Leptin in autoimmunity: many questions, some answers. Tissue Antigens. 2007;70:87.
   PubMed Web of Science ®Google Scholar
• Symmons DP, Bankhead CR, Harrison BJ, et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum. 1997;40:1955.
   PubMed Web of Science ®Google Scholar
• Voigt LF, Koepsell TD, Nelson JL, et al. Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology. 1994;5:525–532.
   PubMed Web of Science ®Google Scholar
• Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, et al. Obesity in rheumatoid arthritis. Rheumatology (Oxford). 2011;50:450.
   PubMed Web of Science ®Google Scholar
• (a) Duntas LH, Biondi B. The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin. Thyroid 2013;23:646–653.
   PubMed Web of Science ®Google Scholar
  (b) Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes 2012;2:e54.
   PubMed Web of Science ®Google Scholar
• Sterry W, Strober BE, Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol. 2007;157:649.
   PubMed Web of Science ®Google Scholar
• Dumas O, Boggs KM, Cozier YC, et al. Prospective study of body mass index and risk of sarcoidosis in US women. Eur Respir J. 2017;50:1701397.
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911–920.
   PubMed Web of Science ®Google Scholar
• Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem. 2007;14:1095–1100.
   PubMed Web of Science ®Google Scholar
• Gvozdenovic BS, Mihailovic-Vucinic V, Vukovic M, et al. Effect of obesity on patient-reported outcomes in sarcoidosis. Int J Tuberc Lung Dis. 2013;17:559–564.
   PubMed Web of Science ®Google Scholar
• Dornbush S, Aeddula NR. Physiology, Leptin. StatPearls. Treasure Island (FL): StatPearls Publishing; 2019.
   Google Scholar
• Gruzdeva O, Borodkina D, Uchasova Dyleva EY, et al. Leptin resistance: underlying mechanisms and diagnosis. Diabetes Metab Syndr Obes. 2019;12:191–198.
   PubMed Web of Science ®Google Scholar
• Otero M, Lago R, Gomez R, et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford). 2006;45:944–950.
   PubMed Web of Science ®Google Scholar
• Dağ ZÖ, Dilbaz B. Impact of obesity on infertility in women. J Turkish German Gynecol Assoc. 2015;16:111–117.
   PubMed Web of Science ®Google Scholar
• Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol. 2012;32:1771–1776.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91.
   PubMed Web of Science ®Google Scholar
• Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev. 2008;29:777–822.
   PubMed Web of Science ®Google Scholar
• Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Disord. 2004;2:82–104.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-alfa in human obesity and insülin resistance. J Clin Invest. 1995;95:2409–2415.
   PubMed Web of Science ®Google Scholar
• Xydakis AM, Case CC, Jones PH, et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab. 2004;89:2697–2703.
   PubMed Web of Science ®Google Scholar
• Ye JH, Li ZZ, Li Y, et al. [Relationship between serum interleukin-10 and insulin resistance in metabolic syndrome]. Nan Fang Yi Ke Da Xue Xue Bao. 2006;26:428–430.
   PubMedGoogle Scholar
• Nishida M, Moriyama T, Sugita Y, et al. Interleukin-10 associates with adiponectin predominantly in subjects with metabolic syndrome. Circ J. 2007;71:1234–1238.
   PubMed Web of Science ®Google Scholar
• Straczkowski M, Kowalska I, Nikolajuk A, et al. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance. Int J Obes. 2007;31:221–225.
   Web of Science ®Google Scholar